1. Hammond ME, Hayes DF, Dowestt M, Allred DC, Hagerty KL, Badve S, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridges version). Arch Pathol Lab Med. 2010;134(7):e48–72.
2. Harvey JM, Clark GM, Osborne CK, Allred DC. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol. 1999;17:1474–81.
3. McCarty KS, Miller LS, Cox EB, Konrath J, McCarty KS Sr. Estrogen receptor analysis, correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med. 1985;109(8):716–21.
4. Horwitz KB, Koseki Y, McGuire WL. Estrogen control of progesterone receptor in human breast cancer: role of estradiol and antiestrogen. Endocrinology. 1978;103(5):1742–51.
5. Cui X, Schiff A, Arpino G, Osborne CK, Lee AV. Biology of progesterone receptor loss in breast cancer and its implication for endocrine therapy. J Clin Oncol. 2005;23(30):7721–35.